Ascor L 500
AssetAlso ascorbic acid, Ascorbate-Meglumine, vitamin c, Ascor L 500® (Ascorbic Acid Injection, USP)
Essential antioxidant and enzyme cofactor involved in collagen synthesis and cellular redox defense
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Oxidative stress and ROS signalling
- 1
- Indication
- 261
- Trials
- 2
- Developers
Indications
1Pharmacokinetic
Phase 1, Completed, NCT02534753, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains3
- Owner and partners2
- Trials261
- Evidence for its targets3
- Competitors6
- Aging relevance1
- Signals3
Every asset’s record: target, stage, trials and the evidence behind it.